Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | RARB | P10826 | 2/20 | 0.51 |
| ▸ | ADH5 | P11766 | 1/20 | 0.50 |
| ▸ | BTK | Q06187 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | XDH | P47989 | 1/20 | 0.44 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | RARG | P13631 | 1/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.43 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.43 |
| ▸ | CCKBR | P32239 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | TNKS | O95271 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4443620 | 0.96 | ALDH1A1 (0.57) | ALDH1A1RARBADH5BTKPARP1 | |
| SCHEMBL21034046 | 0.85 | LTB4R2 (0.51) | ALDH1A1 | |
| SCHEMBL31546329 | 0.82 | ALOX5 (0.61) | ALDH1A1RARBADH5PARP1MAPT | |
| SCHEMBL2646011 | 0.82 | ALDH1A1 (0.58) | ALDH1A1RARBADH5PARP1XDH | |
| SCHEMBL750501 | 0.80 | ALDH1A1 (0.57) | ALDH1A1RARBADH5PARP1XDH | |
| SCHEMBL22273714 | 0.80 | ALOX5 (0.63) | ALDH1A1RARBADH5PARP1XDH | |
| SCHEMBL15059787 | 0.80 | ALDH1A1 (0.57) | ALDH1A1RARBADH5PARP1XDH | |
| SCHEMBL2646013 | 0.80 | ALDH1A1 (0.57) | ALDH1A1RARBADH5PARP1XDH | |
| SCHEMBL16645310 | 0.80 | ALDH1A1 (0.57) | ALDH1A1RARBADH5PARP1XDH | |
| SCHEMBL2963261 | 0.80 | ALDH1A1 (0.61) | ALDH1A1RARBADH5PARP1XDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4562016-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| US-12275723-B2 | Compounds and uses thereof | JANSSEN PHARMACEUTICA NV (BE) | 2025-04-15 | — | — | US | disclosed |
| US-20240400546-A1 | COMPOUNDS AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2024-12-05 | — | — | US | disclosed |
| US-20240300938-A1 | COMPOUNDS AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2024-09-12 | — | — | US | disclosed |
| US-11970486-B2 | Compounds and uses thereof | JANSSEN PHARMACEUTICA NV (BE) | 2024-04-30 | — | — | US | disclosed |
| US-20240124435-A1 | COMPOUNDS AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2024-04-18 | — | — | US | disclosed |
| CN-117777121-A | Compounds and uses thereof | 詹森药业有限公司 | 2024-03-29 | — | — | CN | disclosed |
| WO-2024026483-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| US-11873298-B2 | Compounds and uses thereof | JANSSEN PHARMACEUTICA NV (BE) | 2024-01-16 | — | — | US | disclosed |
| US-11873298-B2 | Compounds and uses thereof | JANSSEN PHARMACEUTICA NV (BE) | 2024-01-16 | — | — | US | disclosed |
| WO-2007039178-A2 | PHENYL-[1,2,4]-OXADIAZOL-5-ONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | SANOFI-AVENTIS (DE) | 2007-04-12 | — | — | WO | disclosed |
| US-20050164954-A1 | N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient | ONO PHARMACEUTICAL CO., LTD. | 2005-07-28 | — | — | US | disclosed |
| US-6900207-B2 | N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-05-31 | — | — | US | disclosed |
| US-20030153508-A1 | Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2003-08-14 | — | — | US | disclosed |
| EP-0975220-B1 | USE OF SULFONYLOXADIAZOLONES AS MICROBICIDES | BAYER CROPSCIENCE AG (DE) | 2003-04-02 | — | — | EP | disclosed |
| EP-1254901-A1 | NITROGEN-CONTAINING 5-MEMBERED CYCLIC COMPOUNDS AND DRUGS CONTAINING THESE COMPOUNDS AS THE ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-11-06 | — | — | EP | disclosed |
| US-6090831-A | FUNGICIDE; BACTERICIDE | BAYER AKTIENGESELLSCHAFT (DE) | 2000-07-18 | — | — | US | disclosed |
| EP-0975220-A1 | USE OF SULFONYLOXADIAZOLONES AS MICROBICIDES | BAYER AG (DE) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998047369-A1 | USE OF SULFONYLOXADIAZOLONES AS MICROBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-10-29 | — | — | WO | disclosed |
| US-4130571-A | Process for preparing 1,2-diacyl-3-glycerylphosphorylcholines | NIPPON SHOJI KAISHA, LTD. (JP) | 1978-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124435-A1 | COMPOUNDS AND USES THEREOF | NLN, ACHE, CLN6 | ALDH1A1 656/4885RARB 3163/4885ADH5 1249/4885 |
| US-20240300938-A1 | COMPOUNDS AND USES THEREOF | NLN, ACHE, CLN6 | ALDH1A1 656/4885RARB 3163/4885ADH5 1249/4885 |
| US-11873298-B2 | Compounds and uses thereof | NLN, ACHE, CLN6 | ALDH1A1 656/4885RARB 3163/4885ADH5 1249/4885 |
| US-20240400546-A1 | COMPOUNDS AND USES THEREOF | NLN, ACHE, CLN6 | ALDH1A1 656/4885RARB 3163/4885ADH5 1249/4885 |
| US-12275723-B2 | Compounds and uses thereof | NLN, ACHE, CLN6 | ALDH1A1 656/4885RARB 3163/4885ADH5 1249/4885 |
| US-20050164954-A1 | N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient | ACIN1, CASP7, CASP10 | ALDH1A1 3847/4885RARB 1769/4885ADH5 2610/4885 |
| US-20030153508-A1 | Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient | ACIN1, CASP7, CASP10 | ALDH1A1 3366/4885RARB 2896/4885ADH5 2583/4885 |
| US-11970486-B2 | Compounds and uses thereof | NLN, ACHE, CLN6 | ALDH1A1 656/4885RARB 3163/4885ADH5 1249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.